← Scroll for more →
BriaCell Therapeutics Corp. (BCTX)
Pharmaceutical Preparations
Latest Price
$4.28
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.69
P/B Ratio
1.59
Institutional Ownership
7.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cable Car Capital, LP | 216.8K | -- | 2.99% | -- | 2026-06-30 |
| Sabby Management, LLC | 80.7K | -- | 1.11% | +6.8K | 2026-06-30 |
| Iridian Asset Management LLC | 65.0K | -- | 0.90% | -- | 2026-06-30 |
| UBS Group AG | 43.6K | -- | 0.60% | +32.1K | 2026-06-30 |
| LuminArx Capital Management LP | 40.0K | -- | 0.55% | +25.0K | 2026-06-30 |
| Hrt Financial LP | 34.9K | -- | 0.48% | -- | 2026-06-30 |
| Jane Street Group, LLC | 26.5K | -- | 0.37% | -- | 2026-06-30 |
| National Bank of Canada | 1.8K | -- | 0.02% | +1.0K | 2026-06-30 |
| Morgan Stanley | 1.0K | -- | 0.01% | -2.0K | 2026-06-30 |
| Federation des caisses Desjardins du Quebec | 450 | -- | 0.01% | -5 | 2026-06-30 |